Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease

BACKGROUND: Approximately 30% of patients who are treated with proton pump inhibitors (PPIs) for gastroesophageal reflux disease (GERD) experience persistent symptoms. No prokinetic agent regiments are useful for symptom relief. AIMS: This study was conducted to examine the effect of adding acotiami...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Hiroshi, Okada, Akihiko, Naora, Kohji, Hongoh, Masafumi, Kinoshita, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394577/
https://www.ncbi.nlm.nih.gov/pubmed/30465175
http://dx.doi.org/10.1007/s10620-018-5377-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394577/
https://www.ncbi.nlm.nih.gov/pubmed/30465175
http://dx.doi.org/10.1007/s10620-018-5377-9

Ejemplares similares